C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2004
12/29/2004	CA2529520A1 Interleukin-21 analogs
12/29/2004	CA2529455A1 Plant limit dextrinase inhibitor
12/29/2004	CA2529282A1 Recombinant igf expression systems
12/29/2004	CA2529051A1 Vaccines, immunotherapeutics and methods for using the same
12/29/2004	CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases
12/29/2004	CA2528845A1 Modified oleosins
12/29/2004	CA2528599A1 Proton-sensing g-protein coupled receptors and dna sequences thereof
12/29/2004	CA2528002A1 Improved method for the recovery of non-segmented, negative-stranded rna viruses from cdna
12/29/2004	CA2527091A1 Interferon gamma-like protein
12/29/2004	CA2526643A1 Use of a vegf receptor gene or gene product
12/29/2004	CA2526640A1 Immunogenic reagents from west nile virus
12/29/2004	CA2525953A1 High titer recombinant influenza viruses for vaccines and gene therapy
12/28/2004	US6835868 For agriculture/horticulture; improved yield; genetic engineering
12/28/2004	US6835867 For genetic mapping; in vitro stem cell cultures
12/28/2004	US6835866 Compositions and methods of modulating cholesterol metabolism
12/28/2004	US6835825 For regulating activation/development/differentiation of hematopoietic cells
12/28/2004	US6835824 Peanut allergens and methods
12/28/2004	US6835823 Anti-TNF antibodies and peptides of human tumor necrosis factor
12/28/2004	US6835822 Diagnosis and therapy of cancer using SGP28-related molecules
12/28/2004	US6835819 Sequences and their use
12/28/2004	US6835818 Mutants of Streptococcal toxin C and methods of use
12/28/2004	US6835816 Mammalian tumor susceptibility genes and their uses
12/28/2004	US6835815 Nod2 nucleic acids and proteins
12/28/2004	US6835814 Protease resistant flint analogs
12/28/2004	US6835813 Testis-specific differentiation-regulatory factor
12/28/2004	US6835812 Human p-Hyde proteins
12/28/2004	US6835810 Fusion protein for use as vector
12/28/2004	US6835809 Thrombopoietic compounds
12/28/2004	US6835806 Stable water soluble polypeptides which are potent inhibitors of endothelial cell proliferation and of angiogenesis.
12/28/2004	US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions
12/28/2004	US6835713 Peptide for use in the prevention and treatment of bacterial infections
12/28/2004	US6835710 Use as ANTITUMOR AGENTS for treating breast, ovarian, brain, or skin tumors
12/28/2004	US6835567 PNS cell lines and methods of use therefor
12/28/2004	US6835565 Alzheimer's disease secretase
12/28/2004	US6835563 Compositions and methods for increasing cholesterol efflux and raising HDL ATP binding cassette transporter protein ABC1
12/28/2004	US6835557 DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
12/28/2004	US6835556 Protein cluster V
12/28/2004	US6835548 Isoforms of mouse serotonin 5-HT2c receptor
12/28/2004	US6835547 Methods for identifying modulators of CCX CKR activity
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835544 Methods of screening for compounds that bind to activin receptor
12/28/2004	US6835539 Nucleic sequences coding for an AT2 interacting proteins interacting with the AT2 receptor and their applications
12/28/2004	US6835538 Method of genetic modification of a wild type viral sequence
12/28/2004	US6835384 Nucleic acids and polypeptides specific of the neisseria genus pathogenic strains
12/28/2004	US6835383 Protein kinase deficient, immunologically active CMVpp65 mutants
12/28/2004	US6835382 Ii peptide therapeutics to enhance antigen presentation
12/28/2004	US6835380 Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
12/28/2004	US6835378 Method and compositions for inhibiting thrombin-induced coagulation
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/26/2004	CA2458893A1 Treatment of chronic human viral hepatitis
12/26/2004	CA2430835A1 Methods for making and breaking prions (prpsc) produced from native prions (prpc), in vitro and from recombinant prion proteins
12/23/2004	WO2004111641A2 Methods for detecting cancer and monitoring cancer progression
12/23/2004	WO2004111608A2 Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions
12/23/2004	WO2004111268A2 Mutations in the slc40a1 gene associated to impaired iron homeostasis
12/23/2004	WO2004111251A2 Modified fiber proteins for efficient receptor binding
12/23/2004	WO2004111250A1 Recombinant adeno-associated virus vector for treatment of alzheimer disease
12/23/2004	WO2004111249A2 Protein constructs containing caspase recognition sites
12/23/2004	WO2004111247A1 Circular expression construct for gene therapeutic applications
12/23/2004	WO2004111244A2 Methods for the production of insulin in plants
12/23/2004	WO2004111240A2 Sequence for the bacillomycin d synthesis in bacillus amyloliquefaciens fzb42
12/23/2004	WO2004111236A1 Fluorescent protein
12/23/2004	WO2004111235A1 Fluorescent protein and pigment protein
12/23/2004	WO2004111234A1 Novel protein
12/23/2004	WO2004111202A2 Neurotransmission-association proteins
12/23/2004	WO2004111200A2 Rtvp-glipr-like compositions and methods for the detection, treatment and prevention of prostate cancer
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004111189A2 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site
12/23/2004	WO2004111090A2 Molecules for targeting and releasing therapeutic compounds, and the use thereof
12/23/2004	WO2004111089A2 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
12/23/2004	WO2004111088A2 Angiogenic factor and inhibitors thereof
12/23/2004	WO2004111087A2 Chemokin-binding protein thap1, methods and use thereof
12/23/2004	WO2004111086A2 Peptide analogues comprising at least one type of aminoacyl aza-$g(b)3 and the use thereof, in particular for therapy
12/23/2004	WO2004111085A1 Angiogenic factor and its medical use
12/23/2004	WO2004111084A2 Peptides enhancing ceh activity or inhibiting acat activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis
12/23/2004	WO2004111082A2 Compound containing polyprotein ns3/ns4 and hcv polypeptide ns5b, expression vectors comprising corresponding nucleic sequences and the therapeutic application thereof
12/23/2004	WO2004111081A2 Antigenic peptides of sars coronavirus and uses thereof
12/23/2004	WO2004111080A1 Epitopes of the cytomegalovirus pp65 protein
12/23/2004	WO2004111078A2 Compounds that modulate the glucagon response and uses thereof
12/23/2004	WO2004111075A2 Alternative reading frame polypeptides for treatment
12/23/2004	WO2004111074A2 In vivo production of a clostridial neurotoxin light chain peptide
12/23/2004	WO2004111072A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
12/23/2004	WO2004110486A1 Functionally reconstituted viral membranes containing adjuvant
12/23/2004	WO2004110483A1 Method and composition of a novel vaccine design for the prevention and treatment of sars
12/23/2004	WO2004110478A1 Inhibitors of cell migration
12/23/2004	WO2004110477A1 Inhibitors of the leukocyte prommp-9/beta(2) integrin complex
12/23/2004	WO2004110472A2 Fusion proteins
12/23/2004	WO2004110471A1 Preventive or remedy for disease associated with apoptosis
12/23/2004	WO2004110470A2 Use of collagen peptides to inhibit infection
12/23/2004	WO2004110390A2 Anti-cd74 immunoconjugates and methods
12/23/2004	WO2004110384A2 Hiv-1 envelope glycoproteins having unusual disulfide structure
12/23/2004	WO2004110372A2 Room temperature storage of organs
12/23/2004	WO2004110369A2 Cell surface protein associated with human chronic lymphocytic leukemia
12/23/2004	WO2004110367A2 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections
12/23/2004	WO2004110365A2 Liver related disease compositions and methods
12/23/2004	WO2004110349A2 Sars t cell epitopes and methods for identifying same
12/23/2004	WO2004094465A8 Synthetic molecules that mimic chemokines
12/23/2004	WO2004090151A3 Method for extracting collagen comprising microbial fermentation
12/23/2004	WO2004083251A3 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
12/23/2004	WO2004081217A3 Method for increasing resistance against stress factors in plants

1 ... 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 ... 2916